You are here :

2010 l February - GB

February 2010


At the heart of progress in research in the field of electrophysiology and cardiovascular technology

Cardiostim, the leading world congress in the field of cardiac rhythm disturbances, will hold its 17th edition, June 16 to 19, at the Nice Acropolis Convention Center.

This inescapable, international, professional event, founded by Jacques Mugica will gather for 4 days over 5,500 scientists, from 93 countries, among whom the most prominent in the field. With the recent arrival of Philippe Ritter, the Congress Chairman, to the Bordeaux University Medical Center, Cardiostim has gained a new and expanded scientific board. These 4 days will be a prime opportunity to talk about technologic progress, debate key current topics, as well as exchange knowledge sought by an audience in search of new clinical and therapeutic techniques.


Showcase for the most advanced current technologies. Cardiostim is a unique meeting point for physicians, engineers and industrials, which promotes enlightening exchanges in the clinical arena, as well as in the technological sector, where physicians are increasingly called upon to participate in the development of innovations.

For Philippe Ritter, Chairman of Cardiostim, “electrophysiology and cardiovascular technology are at the dawn of a new era” with the implementation and application of more accurate and reliable instrumentation, which offers greater relief for patients suffering from cardiac arrhythmias.


The congress is also a recognized site of exchange of information, where training sessions in the English (EDUSTIM) and French (STIMUPRAT) languages allow practitioners to acquire new technical knowledge for their daily practice.


As usual, Cardiostim will highlight the most promising techniques and will focus particularly on:
Techniques of cardiac arrhythmia management, especially radiofrequency ablation.
Implantation of cardiac resynchronization therapy systems with or without defibrillator, capable of preventing the development or worsening of heart failure.
The development of instrumentation compatible with magnetic resonance nuclear imaging, currently contraindicated in recipients of implanted cardiac devices, who stand a 50% chance of needing this investigation in their lifetime.

It will pursue the developments pertaining to:
Haïssaguerre’s syndrome* and the progress made in the study of this recently discovered genetic disorder, cause of syncope and sudden death in individuals apparently free from cardiac disease.
                     (*Professor Michel Haïssaguerre, Chief of the Arrhythmia Service of the Bordeaux University Medical Center has discovered this disorder)
Progress in telecardiology and advances in remote care delivery and transmission of medical information, which will revolutionize the follow-up of pacemaker and defibrillator recipients.

Other topics relevant to this vast scientific field have also been listed on the programs of plenary sessions and workshops.


Media contacts

Catherine Rouillé
Virginie Renouvin
Tél. +33 (0)1 49 74 42 01